OPG secretion by MSCs was reported by Park et al. [118] and others and showed promising results in the treatment of disorders relying on disturbed bone metabolism like osteosarcoma [119], but also in inflammatory diseases like rheumatoid [120] or psoriatic arthritis [121], respectively. Here, TNFRSF11B is linked to osteosarcoma.